Synthetic alcohol: Booze with all the buzz — but without the hangover?

The synthetic alcohol's basis is gamma-aminobutyric acid, an amino acid that targets receptors in the front of the brain that trigger the relaxation and sociability alcohol brings, while avoiding the chaos it wreaks on the body. Credit: Matt Biddulph via CC-BY-SA-2.0
The synthetic alcohol's basis is gamma-aminobutyric acid, an amino acid that targets receptors in the front of the brain that trigger the relaxation and sociability alcohol brings, while avoiding the chaos it wreaks on the body. Credit: Matt Biddulph via CC-BY-SA-2.0

What if you could indulge in your favorite cocktails with no hangover or other ill effects?

That’s one of the goals for researchers working to make one of the world’s oldest vices less harmful. Some are developing hormone shots to help people sober up quickly. Others are working on alcohol substitutes that target receptors in the brain that affect happiness, while dodging those that make imbibers slur and weave.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

GABA receptors are the first contact for alcohol in the brain, opening up and relaxing people, [neuropsychopharmacologist David] Nutt says. But alcohol then also floods the brain with other neurotransmitters that can cause nasty aftereffects.

Creating a substance that targets only the GABA receptors allows the brain to then turn on dopamine and serotonin naturally as the pleasures of the evening take off, he says. “It feels like what a glass of wine feels like. It feels relaxing. It makes you a bit more chatty, a bit more socially engaged with people,” he says of the product GABA Labs is developing, dubbed Alcarelle.

….

The company is working to raise about £8 million (around $10.3 million), with an aim to complete food-safety testing in the U.S. by mid-2026, where it will launch ahead of European and U.K. markets.

This is an excerpt. Read the original post here

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Sep-23-2026-02_36_39-PM
Viewpoint: After firing the entire National Science Board, Trump reshapes funding initiatives. Here’s the good and the bad.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Sep-10-2026-10_36_07-AM
Viewpoint: Even lousy scientific articles can shield authors when they hype dubious health claims and products
sorghum farmers in kenya FARMERS TREND
Here are all the ways CRISPR gene editing is transforming Africa’s staple crops—and there’s a lot more innovation to come
ChatGPT-Image-Sep-30-2026-01_38_36-PM
Viewpoint: Died “with measles” vs. died “from measles”: RFK, Jr.’s dangerously subversive word games
ChatGPT-Image-Sep-30-2026-01_25_34-PM
Blood tests for Alzheimer’s? The latest grifter, social media scam.
ChatGPT-Image-Sep-21-2026-03_15_09-PM
Viewpoint: Chipotle-inspired lesson: 10,000 sick customers suggest that processed foods can be safer than fresh ones
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.